131 related articles for article (PubMed ID: 7159069)
1. Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.
Hampel B; Lode H; Wagner J; Koeppe P
Antimicrob Agents Chemother; 1982 Dec; 22(6):1061-3. PubMed ID: 7159069
[TBL] [Abstract][Full Text] [Related]
2. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
Lode H; Stahlmann R; Dzwillo G; Koeppe P
Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.
Ginsburg CM
J Antimicrob Chemother; 1982 Sep; 10 Suppl B():27-31. PubMed ID: 7142090
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of cefadroxil after oral administration in humans.
La Rosa F; Ripa S; Prenna M; Ghezzi A; Pfeffer M
Antimicrob Agents Chemother; 1982 Feb; 21(2):320-2. PubMed ID: 7073267
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the oral cephalosporins in adults.
Nightingale C
J Int Med Res; 1980; 8(Suppl 1):2-8. PubMed ID: 7439500
[No Abstract] [Full Text] [Related]
6. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics.
Ginsburg CM; McCracken GH
J Pediatr; 1980 Feb; 96(2):340-2. PubMed ID: 7351610
[No Abstract] [Full Text] [Related]
7. Serum and sputum levels of cefaclor.
Simon C; Gatzemeier U
Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
[TBL] [Abstract][Full Text] [Related]
8. Cefadroxil compared with cefaclor in the treatment of streptococcal pneumonia in adults.
ZeLuff B; Catchpole M; Lowe P; Koornhof H; Gentry L
Drugs; 1986; 32 Suppl 3():39-42. PubMed ID: 3803252
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and clinical studies with cefadroxil in paediatrics.
Windorfer A; Bauer P
J Antimicrob Chemother; 1982 Sep; 10 Suppl B():85-91. PubMed ID: 7142099
[No Abstract] [Full Text] [Related]
10. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
Ballantyne FN
Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
Welling PG; Dean S; Selen A; Kendall MJ; Wise R
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of the new cephalosporins.
Brogard JM; Comte F
Antibiot Chemother (1971); 1982; 31():145-210. PubMed ID: 6277241
[No Abstract] [Full Text] [Related]
13. Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.
Lode H; Stahlmann R; Koeppe P
Antimicrob Agents Chemother; 1979 Jul; 16(1):1-6. PubMed ID: 475366
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis.
Randolph MF
Chemotherapy; 1988; 34(6):512-8. PubMed ID: 3243093
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis.
Spyker DA; Gober LL; Scheld WM; Sande MA; Bolton WK
Antimicrob Agents Chemother; 1982 Feb; 21(2):278-81. PubMed ID: 7073265
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
Lode H; Köppe P; Stahlmann R
Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
[TBL] [Abstract][Full Text] [Related]
17. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Larsson P; Lincoln K; Lind L; Sandberg T
Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
Levison ME; Santoro J; Agarwal BN
Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
[TBL] [Abstract][Full Text] [Related]
19. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
Dantzig AH; Tabas LB; Bergin L
Biochim Biophys Acta; 1992 Dec; 1112(2):167-73. PubMed ID: 1457450
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
Gartenberg G; Meyers BR; Hirschmann SZ; Srulevitch E
J Antimicrob Chemother; 1979 Jul; 5(4):465-70. PubMed ID: 489494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
